Express Pharma

NOVEMBER 26, 2024

Spanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond, it offers a comprehensive platform for stakeholders to engage in transformative dialogues and foster strategic partnerships. With exports nearing $27.84 Adam Anderson , Executive VP – Pharma, Informa Markets B.V

Packaging 105

Packaging Biosimilars Pharmaceutical Manufacturing Dosage 105

Pharmaceutical Technology

JULY 2, 2025

How will RFK Jr’s American dream for vaccines play out? The merger, announced in April 2025 , will positively impact Merck’s financial position by contributing to revenues immediately, and is anticipated to be accretive to its earnings per share by 2027. Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 2, 2025

How will RFK Jr’s American dream for vaccines play out? With the additional funds from Sanofi’s investment and current assets on hand, it anticipates sufficient funds to sustain its planned operations in 2027. As of December 2024, the company reported cash reserves of $85.2m.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Takeda anticipates commencing commercialisation efforts for Gammagard liquid ERC in the US by 2026, with plans to follow suit in the European Union (EU) by 2027. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

STAT

SEPTEMBER 12, 2024

This calls for celebration with a cup of stimulation, and we are opening a new package of pecan pie for the occasion. billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate, STAT writes. Sound familiar? Have a great day, everyone.

Packaging 143

Packaging Diabetes Vaccines 143

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? The expansion will be concluded by late 2027, with production capacity increasing from 104 batches annually at peak utilisation to more than 240 batches. Give your business an edge with our leading industry insights.

Communication 52

Communication Packaging Hospitals Drug Pricing 52

Pharmacy Times

JULY 7, 2025

Takeda will discontinue Gammagard S/D by December 2027, transitioning to the new low IgA formulation. Takeda has informed the FDA that the manufacturing of Gammagard S/D will cease in December 2027.

Pharmacy Technician 39

Pharmacy Technician Immunity Immunization Compounding Pharmacies 39